Articles from Evidation

Evidation, the leader in direct-to-participant real-world data and health research, today announced the appointment of Dr. Ghazanfar Khan as Chief Medical Officer.

Evidation, the leader in direct-to-participant real-world data and health research, today announced the appointment of Leslie Oley Wilberforce as Chief Executive Officer. Wilberforce succeeds Christine Lemke, who will continue as an advisor and Board Member.

Evidation, the company creating new ways to measure and improve health in everyday life, and 1upHealth, the leading FHIR® platform provider for claims and clinical data interoperability, are announcing a long-term partnership to advance patient-centered, real-world health research. This partnership will enable consented data sharing and linkage of diverse sources of permissioned real-world data, including health record data and data collected and consented directly from individuals such as digital measures from wearables, validated surveys, symptom diaries, and more.

Frost & Sullivan has named Evidation the 2024 Honoree of the Best Practices Customer Value Leadership Award for Real-World Evidence Solutions in Healthcare. Frost & Sullivan recognizes Evidation's transformative approach in harnessing consented real world data directly from individuals to deeply characterize and understand health and disease.

Today, Evidation, the company creating new ways to measure and improve health in everyday life, is announcing MigraineSmart, a health engagement program on the Evidation app that helps individuals track and better understand their migraine symptoms.

Evidation, the market leader in health research solutions for understanding health in everyday life, will be presenting recent research findings in two accepted abstracts at this year’s International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference in Atlanta, Georgia.

Evidation — the company creating new ways to measure and improve health in everyday life — today announced a landmark partnership with Our Future Health, a national health research initiative and collaboration between the UK’s National Health Service (NHS), public health agencies, non-profits, and leading life sciences companies. Our Future Health will deploy Evidation’s enterprise digital health engagement and measurement platform to conduct a multi-year, longitudinal research program for up to five million participants across the UK.

Evidation, the company creating new ways to measure and improve health in everyday life, today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services (HHS), to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.

Evidation, the company creating new ways to measure and improve health in everyday life, today announced a partnership with USC’s Dornsife Center for Economic and Social Research to incorporate wearable device data into the landmark Understanding America Study. The goal of the partnership is to power research that will generate insights into healthy aging. Evidation and USC will collaborate to integrate a robust wearables dataset into extensive survey data that has been collected as part of the Understanding America Study for almost two decades. Evidation and USC have been working together since 2017 and this work expands upon the NIH-funded American Life in Realtime (ALiR) study, an initiative that achieved a nationally representative digital health benchmark dataset.

Today, as part of National Women’s Health Week, Evidation and Myovant Sciences Ltd. (“Myovant”), a wholly owned subsidiary of Sumitovant Biopharma Ltd. (“Sumitovant”) announced results from a survey exploring the lived experiences of individuals with endometriosis and/or uterine fibroids. The survey results highlight the negative impacts of these conditions on employee and student experiences and quality-of-life, underscoring the need for conversations and accommodations that advance equity for these populations.

This week, Evidation will present alongside collaborators from the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology in New Orleans.

Duke University’s BIG IDEAs Lab and Evidation, the company that connects directly with individuals to measure and improve health in everyday life, announced today that they have established a partnership with the goal of increasing diversity and representation in digital health studies.

Evidation, the company that connects directly with individuals to measure health in everyday life, has launched FluSmart, a digital flu monitoring program that brings together individuals, researchers, and public and private organizations to understand flu at its earliest stages.

Moderna recently conducted a digitally enabled, at-home study examining COVID-19 antibody response over time, made possible by Evidation. A preprint published on MedRxiv, Antibody Response Following COVID-19 Boosters During the Omicron Wave in the United States: A Decentralized, Digital Health, Real-World Study, reports individuals who received Moderna primary shots and boosters had more durable antibody levels than those who received Pfizer. This observational study is believed to be the first study worldwide to use decentralized procedures to assess real-world immunity following COVID-19 vaccination.

Evidation and the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) announced today an initiative to enroll Veterans in Heart Health on Evidation—a specialized heart health program built on the Evidation app that encourages individuals to understand and engage with their cardiovascular health from anywhere, using their smartphones and wearable devices.

Evidation, the company creating new ways to measure and improve health in everyday life, is expanding its decade-long collaboration with Sanofi to build upon their joint real-world data initiatives. This new phase will focus on the co-development of unique datasets to develop and validate new measures of health and wellness.

Evidation is sharing the results of a study conducted in partnership with Sanofi that show convenient, low-cost digital messaging can improve the rate of influenza vaccination in people with diabetes. The study was recently published in npj Digital Medicine, a Nature Portfolio journal. Results are also discussed in detail by study authors in a post on the journal’s blog.